Publications by authors named "C Corpechot"

Claim this Profile
B
Bezafibrate for primary biliary cholangitis: time to act on the evidence.
Christophe Corpechot, Maria-Carlota Londoño, Alejandra Villamil, Henriette Ytting, Atsushi Tanaka

Nat Rev Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis.
Pierre-Antoine Soret, Virginie Steunou, Julien Hedou, Juliette Tokgozoglu, Valeria Pistorio, Christophe Corpechot

Sci Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology, comorbidities, treatments and outcomes of autoimmune liver diseases: A French nationwide study.
Christophe Corpechot, Pierre Hornus, Mallory Cals, Pierre Rinder, Théo Marcille

JHEP Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCB4 disease-causing variants S242R, S346I, T437I and T1077M significantly impair its function and display differential sensitivity to potentiators.
Claire Madry, Ahmad Elbahnsi, Jean-Louis Delaunay, Anne Stary, Sylvie Lagaye, Christophe Corpechot

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of peroxisome proliferator-activated receptor agonists as second-line therapies for primary biliary cholangitis: A systematic review and network meta-analysis.
Adrielly Martins, Nidah S Khakoo, Anish Reddy, John M Reynolds, Christophe Corpechot

Hepatology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis